Lynk Pharmaceuticals has received the green light from the U.S. Food and Drug Administration (FDA) to begin clinical trials of its investigational oral therapy LNK01006, which is being developed for multiple sclerosis (MS) and other neuroinflammatory diseases. “We look forward to advancing this promising molecule into human clinical trials and bringing new therapeutic options to…

The post Injectable Ocrevus® (ocrelizumab) listed on the PBS appeared first on MS Australia. Source: www.msaustralia.org.au

It’s been a minute since I’ve had the inclination to write anything. That probably has a lot to do with the fact that I haven’t really slept in several days creating the perfect storm of suck for me both mentally and physically. Not sleeping is in some ways akin to torture. I wonder when my body…

I was introduced to the spoon theory not long ago in a graduate school class. The spoon theory, created by lupus patient Christine Miserandino, utilizes a kitchen utensil to illustrate the energy budget of a person living with a disability or chronic illness, which helps quantify fatigue. The theory visualizes starting each day with a certain…

Some mornings with multiple sclerosis (MS) feel like being stuck in quicksand. Fatigue appears first, followed by aches, and then the fog that turns simple tasks into mini mountains. On those days, I ask one small question to get moving: What color is my hope today? Dressing for dopamine, or choosing clothes that trigger a…

For most people with multiple sclerosis (MS), the use of disease-modifying therapies, or DMTs, does not affect their perceived pain, according to a survey-based study in Australia. As few as one-third of MS patients who had ever used DMTs reported a change in pain, while one-eighth of those currently using DMTs reported such a change,…

For many people, the holidays are pictured as a “most wonderful time of the year,” filled with parties, gifts, and endless cheer. But for those living with multiple sclerosis (MS), the season often feels different. It can bring a complicated … Continue reading → Source: blog.mymsaa.org

Adherence to either the Mediterranean or the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diets was associated with better performance in certain areas of thinking and memory among people with multiple sclerosis (MS), a U.K. study suggests. The Mediterranean diet reflects foods traditionally eaten in countries around the Mediterranean Sea. It emphasizes fruits, vegetables, legumes, fish,…